AGIO

Agios Pharmaceuticals Inc.

Price

$35.12

return (12m)

-3.04%

p/e

-4.75

p/bv

1.90

DIVIDEND YIELD

0.00%

AGIO price

Agios Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AGIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.20%

3 months

21.99%

1 year

-3.04%

2 years

-22.76%

5 years

-18.70%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AGIO

Valuation

P/E

-4.75

Sector -4.38

Industry -4.38

P/BV

1.90

Sector 2.02

Industry 2.02

P/Revenue (PSR)

19.86

Sector -4.40

Industry -4.40

EV/EBITDA

-12.23

Sector -263.09

Industry -263.09

EV/EBIT

-12.08

Sector -702.90

Industry -702.90

P/EBITDA

-4.31

Sector -4.39

Industry -4.39

P/EBIT

-4.26

Sector -4.73

Industry -4.73

P/Total Assets

1.76

Sector 1.49

Industry 1.49

P/Net Current Assets

3.07

Sector -11.70

Industry -11.70

P/Working Capital

3.02

Sector -3.19

Industry -3.19

EPS

-6.97

Sector -2.14

Industry -2.14

BVPS

17.39

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

92.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-244.08%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-247.09%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.04

Sector 0.03

Industry 0.03

Profitability

ROE

-40.08%

Sector -65.14%

Industry -65.14%

ROA

-37.11%

Sector -65.53%

Industry -65.53%

ROIC

-58.48%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.22

Sector 2.90

Industry 2.90

Net Debt / EBITDA

5.66

Sector -6.07

Industry -6.07

Net Debt / EBIT

5.59

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.60

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.93

Sector 0.41

Industry 0.41

Liabilities/Assets

0.07

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals AGIO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AGIO Agios Pharmaceuticals Inc.	$35.12	-3.04%	0.00%	-4.75	1.90	-40.08%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AGIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Agios Pharmaceuticals

Agios Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (3 people)

United States

19 years

Founded: 2007

2013

Time since IPO - 13 years

562

Employees

Agios Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.95 billion, with shareholders equity totaling $1.03 billion.

The company employs approximately 562 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Agios Pharmaceuticals Inc. reported $98.34 million in revenue, generating net income of $-411.28 million.

Key financial metrics include a P/E ratio of -4.75, a price-to-book (P/B) ratio of 1.90, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AGIO.

Market cap

$1.95 billion

Net worth

$1.03 billion

$1,026,020,000.00

Assets

$1.11 billion

$1,108,420,000.00

Total Shares Outstanding

59.00 million

59,000,000

Average Daily Trading Volume

$1.21 million

$1,207,075.52

Sector

Health Care

Industry

Biotechnology

AGIO

AGIO revenue and profits

Financial Results AGIO

DRAG THE FRAME TO SEE MORE DATA

AGIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Agios Pharmaceuticals (AGIO) today?

A cotação de Agios Pharmaceuticals (AGIO) hoje está em US$ 35.12, com uma variação de -3.04% em relação ao último ano. A cotação de Agios Pharmaceuticals (AGIO) iniciou o ano negociando na casa dos US$ 27.22 e hoje está em US$ 35.12. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Agios Pharmaceuticals (AGIO) e dados de ações do Ibovespa e mercados internacionais.

Quando Agios Pharmaceuticals (AGIO) paga dividendos?

Agios Pharmaceuticals (AGIO) não distribuiu dividendos no último ano.

Is Agios Pharmaceuticals (AGIO) a good investment?

Atualmente, Agios Pharmaceuticals (AGIO) está cotada a US$ 35.12, com um P/L de -4.75, representando um desvio de -320% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -3.04 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -3.04%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Agios Pharmaceuticals (AGIO) stock?

Investir em ações de Agios Pharmaceuticals (AGIO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Agios Pharmaceuticals (AGIO) yield today?

A rentabilidade de Agios Pharmaceuticals (AGIO) foi de -6.20% no último mês, -3.04% no último ano e -18.70% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Agios Pharmaceuticals (AGIO) hoje, o investimento total seria de US$ 3,512.00, com base na cotação atual de US$ 35.12.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 3,405.24
Em 5 anos: US$ 2,855.26
Em 10 anos: US$ 3,512.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AGIO

Agios Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AGIO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING AGIO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Agios Pharmaceuticals

Agios Pharmaceuticals Inc.

United States

19 years

2013

562

PROFIT X PRICE AGIO

Financial Results AGIO

AGIO cash flow

Asset, Revenue and Profit Growth - AGIO

AGIO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions